glp-1 protocol Mapping the effectiveness and risks of receptor agonists Microdose GLP-1 Protocol

Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Bagley is the senior editor of Endocrine News

Ozempic (Semaglutide) Ozempic is a common medication used to support blood sugar management and weight loss

In such cases, anesthesiologists employ appropriate anesthetic techniques and aspiration precautions based on individual risk assessment

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

However, most report that these side effects go away after a few days or weeks

Al Refaie, A